Tag: Sonorous Neurovascular
Sonorous receives US FDA 510(k) clearance for BosCATH neurovascular catheter
Sonorous Neurovascular has announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for BosCATH, a next-generation neurovascular catheter designed to...
Joel Harris replaces David Ferrera as Sonorous CEO
Sonorous Neurovascular has announced management changes that will see Joel Harris—previously the company’s president—assume the role of chief executive officer (CEO), with founder and...
Sonorous gains US FDA breakthrough designation to treat pulsatile tinnitus with...
Sonorous Neurovascular has announced that the US Food and Drug Administration (FDA) has granted a Breakthrough Device designation to its BosSTENT device, which is...
